Search - tctmd.com

Displaying 41 - 58 of 58

Sort: Relevancy | Date

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

News Conference News ACC 2015

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Yael L. Maxwell

March 15, 2015

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

Minimizing Selection Bias Eliminates Transfusion’s Apparent Mortality Link in Acute MI Patients

August 20, 2014

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Conference News ACC 2014

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Jason Kahn

March 31, 2014

News Daily News

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

L.A. McKeown

September 27, 2013

News Conference News ESC 2013

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Caitlin E. Cox

September 01, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

October 26, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

Advertisement

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Minimizing Selection Bias Eliminates Transfusion’s Apparent Mortality Link in Acute MI Patients

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content